Glenmark Pharmaceuticals receives ANDA approval for Atomoxetine capsules

-
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Atomoxetine capsules USP, 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg, the generic version of Strattera capsules, 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg, of Eli Lilly and Company.

According to IMS Health sales data for the 12-month period ending April 2017, the Strattera capsules, 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg market1 achieved annual sales of approximately $1.1 billion.

Glenmark’s current portfolio consists of 117 products authorized for distribution in the U.S. marketplace and approximately 67 ANDA’s pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Stock view :-

Glenmark Pharmaceuticals Ltd ended at Rs 624.55, up by Rs 13.15 or 2.15% from its previous closing of Rs 611.4 on the BSE.

The scrip opened at Rs 610.9 and touched a high and low of Rs 629.7 and Rs 608.85 respectively. A total of 169731(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 17625.43 crore.

The BSE group 'A' stock of face value Rs 1 touched a 52 week high of Rs 993 on 01-Nov-2016 and a 52 week low of Rs 600 on 29-May-2017. Last one week high and low of the scrip stood at Rs 651.7 and Rs 600 respectively.

The promoters holding in the company stood at 46.5 % while Institutions and Non-Institutions held 40.8 % and 12.69 % respectively.
The stock traded below its 200 DMA.

Glenmark Pharmaceuticals Ltd :-
BSE 633.60 9.05 (1.45%)
NSE 633.45 9.65 (1.55%)


Comments

Post a Comment

Popular posts from this blog

Top intraday trading ideas for afternoon trade for Monday 31 December 2018

-
Image
Top intraday trading ideas for afternoon trade for Monday 31 December 2018  NEW DELHI:    Equity benchmarks Sensex and Nifty50 were trading higher on Monday on account of buying in frontline bluechip counters. Markets collated a list of trading ideas from various experts and here's what they had recommended for today's afternoon trade: Manas Jaiswal of manasjaiswal.com Tata Steel is a 'Buy' call with a target price of Rs 540 and a stop loss of Rs 514. Shriram Transport NSE 2.17 % is a 'Buy' call with a target price of Rs 1300 and a stop loss of Rs 1230. NSE LIVE 11:49 | 31-12-2018 Dr. Reddy's Lab is a 'Buy' call with a target price of Rs 2720 and a stop loss of Rs 2630. Kunal Bothra independent market expert Dr. Reddy's Lab is a 'Buy' call with a target price of Rs 2750 and a stop loss of Rs 2600. Chennai Petroleum is a 'Buy' call with a target price of Rs 306 and a stop los
Read more

F&O: Put writing at all immediate strikes shows Nifty may hold up

-
Image
F&O: Put writing at all immediate strikes shows Nifty may hold up  The Nifty50 index opened in the negative but managed to recover sharply from lower levels and headed towards the 10,750 level on Wednesday. It formed a Piercing Line pattern on the daily scale, as it recovered its losses of the last session by more than a half. It has been making lower lows from last four sessions and holds above the 10,750-10,777 zone can negate the same to extend its recent bounce towards 10,850 and then 10,929 levels.  Nifty has reclaimed its 50-day EMA while on the downside it has support at 10,650 and then 10,600 levels.  On the options front, maximum Put OI was at 10,000 followed by 10,500 and 10,700 levels, while maximum Call OI was at 11,000 followed by 10,900 level. Meaningful Put writing was seen at all the immediate strike prices from 10,650 to 10,500 level, which suggests support is intact while Call unwinding was seen at most strike prices till 11,000 level. The options band
Read more

WELCOME TO SMART MONEY FINANCIAL SERVICES

-
Image
               WELCOME TO SMART MONEY FS               WE CREATE THE OPPORTUNITY   "Smart Money Financial Service" is an Investment Advisory having a team consists of highly qualified analysts who are skilled and impeccable in their analysis. These analysts, using their experience and the latest software tools, are able to predict the movements in share market on time and with high accuracy. Please click here for Advisory Ranking: As a result, using our tips, our clients gain the most out of the share market. We provide recommendations for Stocks – Cash and F & O trad. 1. VISION GrowthPress focuses on conducting in-depth research on your customers, your competitors, and your search engine landscape. Using this, we create the right SEO strategy that helps. 2. MISSION You achieve your goals. Search engines are constantly evolving to reflect the complex human behavior. Thus, developing an SEO strategy for your Marketing WordPress Theme website.
Read more